Cadila Pharma launches new lung cancer drug – The Hindu
Newstrack India |
Cadila Pharma launches new lung cancer drug
The Hindu The new drug has been licensed and approved by the Drug Controller General of India (DCGI). Mycidac-C is meant for patients suffering from non-small cell lung cancer (NSCLC). “The drug is affordable, and is many times cheaper than what out competitors … Ancestor of TB germ to fight lung cancerCalcutta Telegraph Cadila Pharma launches affordable drugs for lung cancerNewstrack India Cadila launches low-cost cancer drugTimes of India Jagran Josh –India.Com Health all 22 news articles » |